Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer disease

Blood-based biomarkers in AD—a silver lining on the horizon

One of the main challenges associated with diagnosis of Alzheimer disease (AD) is the identification and validation of blood-based biomarkers. Three recent studies describe different approaches to blood-based biomarker research in AD, and provide hope for a simple, minimally invasive means of diagnosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. [No authors listed] Consensus report of the Working Group on: “Molecular and biochemical markers of Alzheimer's disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol. Aging 19, 109–116 (1998).

  2. Mielke, M. M. et al. Serum ceramides increases the risk of Alzheimer's disease: The Women's Health and Aging Study II. Neurology doi: 10.1212/WNL.0b013e318264e380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Soares, H. D. et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol. http://dx.doi.org/10.1001/archneurol.2012.1070.

  4. Doecke, J. D. et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch. Neurol. http://dx.doi.org/10.1001/archneurol.2012.1282.

  5. Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N. Engl. J. Med. 362, 329–344 (2010).

    Article  CAS  PubMed  Google Scholar 

  6. Verleysen, M. & Damien, F. in Computational Intelligence and Bioinspired Systems, Lecture Notes in Computer Science Vol. 3512 (eds Cabestany, J., Prieto, A. & Sandoval, D. F) 758–770 (Springer-Verlag, Berlin, Heidelberg, 2005).

    Google Scholar 

  7. Ray, S. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359–1362 (2007).

    Article  CAS  Google Scholar 

  8. O'Bryant, S. E. et al. A serum protein-based algorithm for the detection of Alzheimer disease. Arch. Neurol. 67, 1077–1081 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Laske, C. et al. Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int. J. Neuropsychopharmacol. 14, 1147–1155 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Laske, C., Stransky, E., Fritsche, A., Eschweiler, G. W. & Leyhe, T. Inverse association of cortisol serum levels with T-tau, P-tau181 and P-tau231 peptide levels and T-tau/Aβ1–42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur. Arch. Psychiatry Clin. Neurosci. 259, 80–85 (2009).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laske, C. Blood-based biomarkers in AD—a silver lining on the horizon. Nat Rev Neurol 8, 541–542 (2012). https://doi.org/10.1038/nrneurol.2012.173

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2012.173

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing